Testing effectiveness (Phase 2)Study completedNCT01231685
What this trial is testing
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Who this might be right for
HIVHepatitis CLiver Fibrosis
McGill University Health Centre/Research Institute of the McGill University Health Centre 9